Immediate Impact
2 from Science/Nature 67 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Works of James M. Randall being referenced
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
2017
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| James M. Randall | 180 | 183 | 154 | 19 | 389 | |
| Giorgia Guaitoli | 160 | 223 | 117 | 27 | 420 | |
| Raquel Andrés | 110 | 151 | 145 | 30 | 437 | |
| Bérengère Dadone | 169 | 119 | 101 | 17 | 372 | |
| Kang Qin | 221 | 163 | 128 | 16 | 383 | |
| Bryan Wong | 108 | 150 | 75 | 20 | 418 | |
| Laura Santos | 104 | 103 | 94 | 21 | 346 | |
| L Anselmi | 80 | 183 | 98 | 17 | 346 | |
| Sheau Wen Lok | 80 | 233 | 141 | 24 | 417 | |
| Aiko Nagayama | 86 | 265 | 100 | 26 | 378 | |
| Shangxiang Chen | 132 | 173 | 98 | 17 | 387 |
All Works
Loading papers...